Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
J Bone Min Res
Understanding peptide safety profiles across different compound classes helps contextualize these risks
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV
US$ 29.49
US$ 23.71
US$ 29.74
US$ 20.04
US$ 28.88
US$ 25.78
